Tokyo Tape
Sign in
← Ensuiko Sugar Refining

Quarterly report · Q2

2112.TEDINET S100S41D
Period2023-04-01 → 2023-09-30
Filed2023-11-02
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥15.6bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥27.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥13.4bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥546m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥274m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.2bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥731m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥244m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.2bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥244m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥901m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥498m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥138m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥901m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥138m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥26.2bnat 2023-09-30Cons.Assets
Total assets¥25.9bnat 2023-03-31Cons.Assets
Total assets¥25.2bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥13.7bnat 2023-09-30Cons.Liabilities
Total liabilities¥14.8bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.5bnat 2023-09-30Cons.Net assets
Net assets / equity¥11.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥10.4bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.4bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥2.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥1.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥434m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥447m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥104m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥76m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥374m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥172m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥33.012023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.482023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.282022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥5.12022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.142022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio47.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio42.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio41.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-09-30¥67m
Otherother segmentsrevenue external2023-04-01 → 2023-09-30¥59m
Otherother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥8m
Otherother segmentssegment profit2023-04-01 → 2023-09-30¥37m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥59m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥59m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥621m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2023-04-01 → 2023-09-30¥964m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2023-04-01 → 2023-09-30¥927m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥37m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2023-04-01 → 2023-09-30¥211m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥13m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2023-04-01 → 2023-09-30¥919m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥15.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥15.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥59m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥1.2bn
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥67m
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥59m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥8m
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥30m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥55m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥55m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥577m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2022-04-01 → 2022-09-30¥925m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2022-04-01 → 2022-09-30¥891m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥34m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2022-04-01 → 2022-09-30¥238m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥13m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2022-04-01 → 2022-09-30¥582m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥55m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥851m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 498
ItemContextValueUnit
Purchase of intangible assets inv cfCurrentYTDDuration－JPY
Purchase of investment securities inv cfPrior1YTDDuration-0JPY
Purchase of investment securities inv cfCurrentYTDDuration-0JPY
Proceeds from sales of investment securities inv cfPrior1YTDDuration－JPY
Proceeds from sales of investment securities inv cfCurrentYTDDuration62000000JPY
Payments of loans receivable inv cfPrior1YTDDuration-470000000JPY
Payments of loans receivable inv cfCurrentYTDDuration-460000000JPY
Collection of loans receivable inv cfPrior1YTDDuration436000000JPY
Collection of loans receivable inv cfCurrentYTDDuration455000000JPY
Other net inv cfPrior1YTDDuration-3000000JPY
Other net inv cfCurrentYTDDuration1000000JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-172000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-76000000JPY
Net increase decrease in short term loans payable fin cfPrior1YTDDuration－JPY
Net increase decrease in short term loans payable fin cfCurrentYTDDuration-800000000JPY
Proceeds from long term loans payable fin cfPrior1YTDDuration－JPY
Proceeds from long term loans payable fin cfCurrentYTDDuration800000000JPY
Repayment of long term loans payable fin cfPrior1YTDDuration-1040000000JPY
Repayment of long term loans payable fin cfCurrentYTDDuration-1027000000JPY
Purchase of treasury stock fin cfPrior1YTDDuration-0JPY
Purchase of treasury stock fin cfCurrentYTDDuration－JPY
Cash dividends paid fin cfPrior1YTDDuration-135000000JPY
Cash dividends paid fin cfCurrentYTDDuration-136000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-1175000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-1163000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration11000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration5000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-1233000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-799000000JPY
Cash and cash equivalentsPrior2YearInstant3533000000JPY
Cash and cash equivalentsPrior1YearInstant2212000000JPY
Cash and cash equivalentsPrior1QuarterInstant2300000000JPY
Cash and cash equivalentsCurrentQuarterInstant1413000000JPY
Products warehouse and transportation expenses sgaPrior1YTDDuration479000000JPY
Products warehouse and transportation expenses sgaCurrentYTDDuration466000000JPY
Sales promotion expenses sgaPrior1YTDDuration6000000JPY
Sales promotion expenses sgaCurrentYTDDuration8000000JPY
Payrolls allowances and compensation sgaPrior1YTDDuration223000000JPY
Payrolls allowances and compensation sgaCurrentYTDDuration215000000JPY
Provision for compensation sgaPrior1YTDDuration48000000JPY
Provision for compensation sgaCurrentYTDDuration46000000JPY
Retirement benefit expenses sgaPrior1YTDDuration11000000JPY
Retirement benefit expenses sgaCurrentYTDDuration12000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E00361-000SugarReportableSegmentsMember12434000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E00361-000BiotechnologyReportableSegmentsMember891000000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember59000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember13384000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration13384000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E00361-000SugarReportableSegmentsMember13000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass